| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/03/2004 | US20040106149 Novel gpcr hfrbn63 |
| 06/03/2004 | US20040106143 Monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040106104 Using viricide to prevent viral infection of mammalian cellscells by blocking the interaction of the viral envelope protein with one or more of the host cell receptor proteins |
| 06/03/2004 | US20040106095 Functional cardiomyocytes from human embryonic stem cells |
| 06/03/2004 | US20040106093 Transgenic erythrocytes for use as tools in identifying modulators of cell proliferation |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/03/2004 | US20040105862 Human TIMP-1 antibodies |
| 06/03/2004 | US20040105854 monoclonal or polyclonal antibodies with histidine polypeptides for immunization |
| 06/03/2004 | US20040105845 Delivering a genetic sequence to cells for gene therapy |
| 06/03/2004 | US20040105841 Interferons, uses and compositions related thereto |
| 06/03/2004 | CA2506935A1 Isolation of sperm cells from other biological materials using microfabricated devices and related methods thereof |
| 06/03/2004 | CA2506695A1 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 06/03/2004 | CA2506050A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | CA2483870A1 Interacting site for gp41 on gp120 of hiv-1 |
| 06/02/2004 | EP1424394A2 TAT transdominant variants from HIV virus |
| 06/02/2004 | EP1424389A1 Process for preparing hematopoietic stem cells |
| 06/02/2004 | EP1424388A1 Method of enriching and/or propagating non-embryonic stem cells while preventing differentiation |
| 06/02/2004 | EP1424387A1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 06/02/2004 | EP1424344A1 Modified cDNA factor VIII and its derivates |
| 06/02/2004 | EP1424342A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/02/2004 | EP1424082A1 Method of regenerating bone/chondral tissues by transferring transcriptional factor gene |
| 06/02/2004 | EP1423756A2 Method of lift-off microstructuring deposition material on a substrate, substrates obtainable by the method, and use thereof |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423695A2 Androgen receptor knock-out transgenic animals |
| 06/02/2004 | EP1423527A1 System for detecting protease |
| 06/02/2004 | EP1423525A1 Recombinant mva capable of expressing structural hcv antigens |
| 06/02/2004 | EP1423524A2 Method of protein production in plants |
| 06/02/2004 | EP1423522A2 Hepatitis c virus replicons and replicon enhanced cells |
| 06/02/2004 | EP1423519A2 G-protein coupled receptor and dna sequences thereof |
| 06/02/2004 | EP1423517A2 Creation of artificial internal ribosome entry site (ires) elements |
| 06/02/2004 | EP1423516A2 Identification of eukaryotic internal ribosome entry site (ires) elements |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423510A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 06/02/2004 | EP1423509A2 Differentiation of neural stem cells and therapeutic use thereof |
| 06/02/2004 | EP1423504A2 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
| 06/02/2004 | EP1423503A2 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd |
| 06/02/2004 | EP1423502A2 Spatially directed ejection of cells from a carrier fluid |
| 06/02/2004 | EP1423432A2 Interleukin-1 beta antibodies |
| 06/02/2004 | EP1423431A2 Antibodies to vla-1 |
| 06/02/2004 | EP1423428A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 06/02/2004 | EP1423427A2 Nogo receptor homologues and their use |
| 06/02/2004 | EP1423426A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
| 06/02/2004 | EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423420A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation |
| 06/02/2004 | EP1423415A2 Intracellular signaling molecules |
| 06/02/2004 | EP1423409A2 Gastrokines and derived peptides including inhibitors |
| 06/02/2004 | EP1423403A2 13 human secreted proteins |
| 06/02/2004 | EP1423144A2 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
| 06/02/2004 | EP1423139A2 New use of artemin, a member of the gdnf ligand family |
| 06/02/2004 | EP1423082A2 Plasma protein matrices and methods for their preparation |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1422999A2 Hypertonic reduction of chilling injury |
| 06/02/2004 | EP1422991A2 Method for increasing stress tolerance in plants |
| 06/02/2004 | EP1330514B1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1169378A4 Preparing porous hydrogel products |
| 06/02/2004 | EP0981541B1 Psca: prostate stem cell antigen |
| 06/02/2004 | EP0687294B1 Human liver epithelial cell lines |
| 06/02/2004 | CN1501815A New interferon beta-like molecules |
| 06/02/2004 | CN1500880A Method for producing saussurea involucrata polysaccharide by cell culture |
| 06/02/2004 | CN1500811A Confluent protein of human interferon and human IgGFc variant without cracking ability and preparing method thereof |
| 06/02/2004 | CN1152051C Trichosanthin mutant and preparing method thereof |
| 06/02/2004 | CN1151997C Culture liquid for rescue culture and seedling culture of disease-resistant non-kernel grape buds |
| 06/01/2004 | US6743968 Nucleotide sequences coding polypeptides for use in the generation of disease, enzyme, antibiotic, insect and herbicide resistant plants |
| 06/01/2004 | US6743967 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 06/01/2004 | US6743908 For use in cancer diagnosis and therapy |
| 06/01/2004 | US6743896 Protien for use in the treatment of infection and tumors |
| 06/01/2004 | US6743783 Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine |
| 06/01/2004 | US6743631 Non-primate mammalian cell lines having no endogenous retroviral sequences for packaging; envelope proteins; gag/pol genes |
| 06/01/2004 | US6743629 Nutrient broth for use in the propagation of swine embryos |
| 06/01/2004 | US6743628 Comprises neuron differentiation growth factor cultures; for treating neurodegenerative disorders |
| 06/01/2004 | US6743626 Artificial salivary gland |
| 06/01/2004 | US6743624 Process for continuous purification and concentration of leukocytes from blood |
| 06/01/2004 | US6743622 Homologous recombination antibody expression system for murine cells |
| 06/01/2004 | US6743617 Can be used against bacterial infections, as digestive enzyme in some mollusks which live on bacteria, anti-tumor agent |
| 06/01/2004 | US6743616 Highly productive alpha-amylases |
| 06/01/2004 | US6743611 For encoding clover yellow vein virus nuclear inclusion-a proteins; proteases; aminopeptidases |
| 06/01/2004 | US6743603 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 06/01/2004 | US6743577 Methods of using cyanovirins to inhibit viral infection |
| 06/01/2004 | US6743575 Colution for use in the preservation of viable human tissues |
| 06/01/2004 | US6743574 For improved durability, function, and recellularization post-implantation |
| 06/01/2004 | US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/01/2004 | CA2240681C Creation and use of multiple gradients in electrophoresis in gel slabs and in capillaries |
| 06/01/2004 | CA2037677C Process for production of exogenous gene or its product in plant cells |
| 05/29/2004 | CA2451584A1 Modified cdna factor viii and its derivatives |
| 05/27/2004 | WO2004044553A2 Lepidoptera voltage-gated calcium channels |
| 05/27/2004 | WO2004044217A2 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/27/2004 | WO2004044209A1 A method of detection |
| 05/27/2004 | WO2004044201A1 Signaling proteins participating in immunopotentiation by virus-origin double-stranded rna and endotoxin and genes thereof |
| 05/27/2004 | WO2004044198A1 Antibodies recognizing chondroitin sulfate b and chondroitin sulfate e |
| 05/27/2004 | WO2004044188A1 Cultivation of hair inductive cells |
| 05/27/2004 | WO2004044182A2 Highly permissive cell lines for hepatitis c virus replication |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044158A2 Human embryonic stem cell cultures, and compositions and methods for growing same |
| 05/27/2004 | WO2004044156A2 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/27/2004 | WO2004044150A2 Systems for gene targeting and producing stable genomic transgen e insertions |